Is there a path forward for immunotherapy in patients with myelodysplastic syndromes? | Aplastic Anemia & MDS International Foundation Return to top.

Is there a path forward for immunotherapy in patients with myelodysplastic syndromes?

Journal Title: 
Lancet Hematology
Primary Author: 
Stahl M
Author(s): 
Stahl M, DeZern AE
Original Publication Date: 
Wednesday, January 31, 2024
Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.